Live Analyst Rating Changes 24315 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Kevin Heal
ARG

Kevin Heal

Argus Research
Wall Street Analyst
★★★☆☆
#1127
on 13Foresight · ranked by our own returns
66%
Success Rate
+5.3%
Average Return
33 of 50 calls profitable · -6.5% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 66% of Kevin Heal's ratings turned a profit when each position was held for 1 year — averaging +5.3% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

35 Buy 10 Hold 0 Sell
Kevin's Stock Coverage 36 ratings · 2026-08-13
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
MCO
Moody's
 Jul 31, 2026 BUY Strong Buy
+6.3% avg upside
33 analysts
 — -0.3% ·
AMP
Ameriprise Financial
 Jul 30, 2026 BUY Buy
-10.0% avg upside
18 analysts
$590.00
4.32% Upside
 +5.1% ·
CFG
Citizens Financial
 Jul 29, 2026 BUY Strong Buy
-0.9% avg upside
25 analysts
$80.00
8.32% Upside
 +4.6% ·
RJF
Raymond James Financial
 Jul 29, 2026 BUY Buy
-2.3% avg upside
17 analysts
$196.00
8.08% Upside
 +2.8% ·
KEY
KeyCorp
 Jul 28, 2026 BUY Strong Buy
+6.0% avg upside
30 analysts
$25.00
9.22% Upside
 +1.1% ·
MSCI
MSCI
 Jul 28, 2026 BUY Strong Buy
+10.9% avg upside
28 analysts
$660.00
17.16% Upside
 -0.7% ·
AGNC
AGNC Investment
 Jul 27, 2026 HOLD Buy
+17.6% avg upside
19 analysts
 — +4.0% ·
CB
Chubb
 Jul 24, 2026 BUY Buy
-7.4% avg upside
33 analysts
$396.00
15.26% Upside
 -3.5% ·
FITB
Fifth Third Bancorp
 Jul 21, 2026 BUY Strong Buy
-5.9% avg upside
32 analysts
$63.00
8.66% Upside
 +1.1% ·
TSE:SLF
Sun Life Financial
 Jun 09, 2026 BUY Buy
-4.8% avg upside
17 analysts
$112.96
1.04% Upside
 +10.8% ·
PRU
Prudential Financial
 Jun 08, 2026 HOLD Hold
-13.6% avg upside
29 analysts
$103.72
15.40% Downside
 -0.0% ·
BRK.B
Berkshire Hathaway B
 Jun 04, 2026 BUY Buy
-17.9% avg upside
9 analysts
 — +5.9% ·
MKL
Markel
 Jun 03, 2026 HOLD Buy
-5.1% avg upside
10 analysts
 — +3.5% ·
ICE
Intercontinental Exchange
 May 28, 2026 BUY Strong Buy
+15.6% avg upside
24 analysts
$190.00
25.57% Upside
 +5.1% ·
ALL
Allstate
 May 27, 2026 BUY Buy
-13.5% avg upside
36 analysts
$238.00
7.00% Downside
 +26.2% ·
SPGI
S&P Global
 May 21, 2026 BUY Strong Buy
+22.0% avg upside
34 analysts
 — +4.1% ·
RITM
Rithm Capital
 May 08, 2026 BUY Strong Buy
+26.0% avg upside
16 analysts
$12.00
17.26% Upside
 +8.0% ·
ZION
Zions Bancorporation National Association
 Apr 21, 2026 BUY Hold
-9.1% avg upside
34 analysts
$70.00
2.59% Downside
 +16.1% ·
RF
Regions Financial
 Apr 20, 2026 BUY Buy
-6.0% avg upside
33 analysts
$31.00
1.82% Downside
 +12.2% ·
TRV
Travelers Companies
 Apr 17, 2026 BUY Hold
-13.5% avg upside
33 analysts
$330.00
10.77% Downside
 +23.6% ·
UWMC
UWM Holding
 Mar 30, 2026 HOLD Buy
+252.8% avg upside
18 analysts
$3.47
129.86% Upside
 -54.5% ·
COIN
Coinbase Global
 Mar 23, 2026 HOLD Buy
+53.3% avg upside
45 analysts
 — -23.3% ·
MKTX
Marketaxess Holdings
 Mar 17, 2026 HOLD Hold
-1.3% avg upside
15 analysts
 — -8.7% ·
CME
CME Group
 Mar 03, 2026 HOLD Buy
+0.7% avg upside
25 analysts
 — -15.4% ·
MET
Metlife
 Dec 08, 2025 BUY Strong Buy
-9.5% avg upside
31 analysts
$90.00
6.89% Downside
 +27.5% ·
HIG
Hartford Insurance
 Nov 24, 2025 BUY Buy
-4.8% avg upside
32 analysts
$155.00
12.76% Upside
 +4.7% ·
BHF
Brighthouse Financial
 Sep 02, 2025 HOLD Hold
+3.0% avg upside
20 analysts
 — +29.8% ·
AIG
American International Group
 Aug 20, 2025 BUY Buy
+10.0% avg upside
33 analysts
$90.00
18.13% Upside
 -3.7% ·
PGR
Progressive
 Aug 08, 2025 HOLD Buy
+3.6% avg upside
29 analysts
 — -7.0% ·
AJG
Arthur J Gallagher & Co
 Aug 08, 2025 BUY Strong Buy
+9.3% avg upside
31 analysts
$330.00
29.16% Upside
 -13.3% ·
HBAN
Huntington Bancshares
 Apr 25, 2025 BUY Strong Buy
+5.4% avg upside
27 analysts
$17.00
4.91% Downside
 +18.3% ·
RKT
Rocket Companies
 Mar 24, 2025 HOLD Buy
+20.8% avg upside
27 analysts
 — +3.0% ·
NDAQ
Nasdaq
 Feb 10, 2025 BUY Strong Buy
+2.4% avg upside
25 analysts
$88.00
8.11% Downside
 +2.9% ·
NLY
Annaly Capital
 Feb 04, 2025 BUY Strong Buy
-0.2% avg upside
19 analysts
 — +28.8% ·
ETR
Entergy
 Aug 27, 2024 BUY Strong Buy
+5.8% avg upside
29 analysts
 — +54.9% ·
CBOE
Cboe Global Markets
 Nov 16, 2023 HOLD Hold
-8.9% avg upside
24 analysts
 — +14.3% ·
🔒 31 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Kevin Heal — Frequently Asked Questions
How accurate are Kevin Heal's stock ratings?
Based on the calls 13Foresight could measure, about 66% of Kevin's ratings were profitable over a one-year hold, with an average return of +5.3% per rating, or -6.5% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Kevin ranked on 13Foresight?
Kevin Heal is currently ranked #1127 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Kevin cover?
Kevin most recently has ratings on MCO, AMP, CFG, RJF, KEY, MSCI, AGNC, CB, FITB, TSE:SLF, PRU, BRK.B and 24 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.